Literature DB >> 7673770

Opioid rotation for toxicity reduction in terminal cancer patients.

N D de Stoutz1, E Bruera, M Suarez-Almazor.   

Abstract

Accumulation of active (toxic) metabolites of opioids might explain cases of opioid toxicity when high doses are used for long periods of time. Other mechanisms of late toxicity of opioids may be found at the receptor level. Whatever the cause, a change of opioids using equianalgesic doses can be expected to improve symptoms of toxicity in some patients, while maintaining pain control. We reviewed the experience with this technique in patients admitted to the Palliative Care Unit of the Edmonton General Hospital. Of 191 patients, 80 underwent opioid rotation (OR) for cognitive failure, hallucinations, myoclonus, nausea and vomiting, local toxicity, and persistent pain. These leading symptoms improved in 58/80 patients (73%, P < 0.01). Pain control, as measured on a 10-cm visual analogue scale (VAS), improved from 4.4 +/- 2.3 to 3.6 +/- 2.0 (P < 0.004) at a dose significantly lower than that predicted to be equianalgesic (577 +/- 1535 mg before OR versus 336 +/- 593 mg after OR, P < 0.04). We conclude that symptoms of opioid toxicity can be relieved by OR, and that a choice of two or three different opioids is necessary to obtain satisfactory long-term pain control.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673770     DOI: 10.1016/0885-3924(95)90924-c

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  53 in total

Review 1.  Alternative opioids to morphine in palliative care: a review of current practice and evidence.

Authors:  M Barnett
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

Review 2.  Recent developments: management of pain.

Authors:  Anita Holdcroft; Ian Power
Journal:  BMJ       Date:  2003-03-22

3.  Equianalgesic doses of opioids - their use in clinical practice.

Authors:  Douglas Natusch
Journal:  Br J Pain       Date:  2012-02

Review 4.  Contribution to variability in response to opioids.

Authors:  Geoffrey W Hanks; Colette Reid
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

Review 5.  Advances in opioid therapy and formulations.

Authors:  Declan Walsh
Journal:  Support Care Cancer       Date:  2004-12-14       Impact factor: 3.603

6.  Advertisement woes.

Authors:  George Vautour
Journal:  CMAJ       Date:  2005-12-06       Impact factor: 8.262

7.  Advertisement woes.

Authors:  Saifee Rashiq
Journal:  CMAJ       Date:  2005-12-06       Impact factor: 8.262

Review 8.  [Palliative pain therapy, cannabinoids].

Authors:  L Radbruch; F Elsner
Journal:  Internist (Berl)       Date:  2005-10       Impact factor: 0.743

Review 9.  [Cancer pain therapy].

Authors:  F Nauck
Journal:  Urologe A       Date:  2009-10       Impact factor: 0.639

10.  Standard therapy with opioids in chronic pain management : ORTIBER study.

Authors:  Antonio Gatti; Carlo Reale; Roberto Occhioni; Marta Luzi; Alessandra Canneti; Claudia De Polo; Martina Gubernari; Massimo Mammucari; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.